Clinical trials for Neurofibroma
5 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- ACTIVE NOT RECRUITINGN/ANCT06175637Observational Study to Evaluate the Effect and Safety of Selumetinib in Pediatric Patients With NF1-PNsAstraZeneca · PI: Xin Ni, PhD
- ACTIVE NOT RECRUITINGN/ANCT05891847Non-interventional Study of Patients With PN NF1 Starting Selumetinib in RussiaAstraZeneca
- RECRUITINGN/ANCT05199376Evaluation of Percutaneous Cryotherapy in the Treatment of Plexiform Neurofibromas and Unresectable Neurofibromas in Neurofibromatosis Type 1Centre Leon Berard · PI: Patrick COMBEMALE, MD
- ACTIVE NOT RECRUITINGPhase 2NCT03962543MEK Inhibitor Mirdametinib (PD-0325901) in Patients With Neurofibromatosis Type 1 Associated Plexiform NeurofibromasSpringWorks Therapeutics, Inc. · PI: Christopher L Moertel, MD
- RECRUITINGPhase 1NCT02390752Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) and Tenosynovial Giant Cell Tumor ...National Cancer Institute (NCI) · PI: Rosandra N Kaplan, M.D.